Global IN-VITRO DIAGNOSTICS Market Expected To Reach USD 77.0 Billion By 2021

Date: 2017-09-04

In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to: Help detect infection, Diagnose a medical condition, Prevent disease, Monitor drug therapies, and then to judge products and services of diseases or bodily functions.

According to the estimation, the global IN-VITRO DIAGNOSTICS market was estimated to be valued at USD 58.7 billion in 2016, and is expected to reach USD 77.0 billion by 2021, growing at a CAGR of 5.2% during the forecast period from 2017 to 2021.

By the applications, the market can be further divided into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases and other indications. Based on the end users, the IVDs market is also divided into standalone laboratory, hospitals, academics & medical schools, point of care and others, among them, hospitals occupied the largest market share in 2016.

In terms of geographies, North America was the largest market of the IVDs in 2016, and will continue to maintain in the next five years, followed by Europe. The Asia Pacific region will be the fastest growing market of the IVDs during the forecast period.

From the global market perspective, at present, IVD in developed countries  of mature market has reached a relatively stable stage, the future growth of European and American countries is expected to be around 5-6%, its momentum has shown a steady decline, Japan’s growth rate is only 2%. The ROW countries are expected growth of 10% in the future.
The Leading Companies in the IVDs Market are the following

Read Full Report:

Joanna | Executive – International Business and partner Relations
E-mail: | Tel: 1-510-400-8520


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample